Jade Biosciences (JBIO) Leases (2021 - 2026)

Jade Biosciences posted quarterly Leases of $690000.0 for Q1 2026, up 336.71% year-on-year from $158000.0 in Q1 2025, and down 4.96% on a QoQ basis from $726000.0 in Q4 2025.

Jade Biosciences (JBIO) has 6 years of Leases data on file, last reported at $690000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Leases rose 336.71% year-over-year to $690000.0; the trailing twelve-month figure through Mar 2026 stood at $690000.0 (up 336.71% YoY), and the FY2025 full-year result was $726000.0, changed N/A from the prior year.
  • Leases for Q1 2026 stood at $690000.0, down from $726000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.2 million in Q2 2022 and bottomed at $158000.0 in Q1 2025.
  • The 5-year median for Leases is $725500.0 (2024), against an average of $720375.0.
  • The widest annual swing landed in 2025, when Leases plunged 78.21%; it then jumped 336.71% in 2026.
  • A 5-year view of Leases shows it stood at $1.0 million in 2022, then sank by 38.78% to $614000.0 in 2023, then sank by 57.82% to $259000.0 in 2024, then jumped by 180.31% to $726000.0 in 2025, then declined by 4.96% to $690000.0 in 2026.
  • The last three Leases figures came in at $690000.0 (Q1 2026), $726000.0 (Q4 2025), and $740000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Jade Biosciences 1.06 Bn 1.06 Bn - 690,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 690,000.00
Dec 31, 2025 726,000.00
Sep 30, 2025 740,000.00
Jun 30, 2025 777,000.00
Mar 31, 2025 158,000.00
Sep 30, 2024 259,000.00
Jun 30, 2024 621,000.00
Mar 31, 2024 725,000.00
Dec 31, 2023 614,000.00
Sep 30, 2023 713,000.00
Jun 30, 2023 811,000.00
Mar 31, 2023 908,000.00
Dec 31, 2022 1.00 Mn
Sep 30, 2022 1.09 Mn
Jun 30, 2022 1.19 Mn
Mar 31, 2022 499,000.00
Dec 31, 2021 542,000.00
Sep 30, 2021 583,000.00